Skip to main content

Advertisement

ADVERTISEMENT

Psychedelics Business

News
02/11/2022
Tom Valentino, Digital Managing Editor
Mindcure announced that its board of directors has formed a special committee to conduct a review of the company’s strategic direction, while Novamind has begun enrolling participants in a Phase II trial sponsored by Alto Neuroscience.
Mindcure announced that its board of directors has formed a special committee to conduct a review of the company’s strategic direction, while Novamind has begun enrolling participants in a Phase II trial sponsored by Alto Neuroscience.
Mindcure announced that its...
02/11/2022
Behavioral Healthcare Executive
News
01/21/2022
Tom Valentino, Digital Managing Editor
MindMed has accepted its first patient into a study, while a research project for Numinus Wellness has cleared several regulatory hurdles.
MindMed has accepted its first patient into a study, while a research project for Numinus Wellness has cleared several regulatory hurdles.
MindMed has accepted its first...
01/21/2022
Behavioral Healthcare Executive
News
01/14/2022
Tom Valentino, Digital Managing Editor
Numinus Wellness and Pacific Neuroscience Institute have announced developments around clinical trials, while Delix Therapeutics has secured new funding to expand its operations.
Numinus Wellness and Pacific Neuroscience Institute have announced developments around clinical trials, while Delix Therapeutics has secured new funding to expand its operations.
Numinus Wellness and Pacific...
01/14/2022
Behavioral Healthcare Executive
News
01/11/2022
Tom Valentino, Digital Managing Editor
Health Canada announced it has amended its Special Access Program to allow qualified physicians to request access to psychedelic treatments for serious, treatment-resistant or life-threatening health conditions when other therapies have...
Health Canada announced it has amended its Special Access Program to allow qualified physicians to request access to psychedelic treatments for serious, treatment-resistant or life-threatening health conditions when other therapies have...
Health Canada announced it has...
01/11/2022
Psych Congress Network
BHE Psychedelics Podcast
BHE Podcast
01/07/2022
Brian Mears, Alleviant Health Centers founder, president and CEO, discusses best practices for behavioral healthcare providers who are interested in adding a ketamine-assisted treatment option to their service offerings.
Brian Mears, Alleviant Health Centers founder, president and CEO, discusses best practices for behavioral healthcare providers who are interested in adding a ketamine-assisted treatment option to their service offerings.
Brian Mears, Alleviant Health...
01/07/2022
Behavioral Healthcare Executive
News
01/05/2022
Tom Valentino, Digital Managing Editor
Otsuka Pharmaceutical’s McQuade Center for Strategic Research and Development (MSRD) has announced a collaboration with Mindset Pharma to support the development of psychedelic medicines.
Otsuka Pharmaceutical’s McQuade Center for Strategic Research and Development (MSRD) has announced a collaboration with Mindset Pharma to support the development of psychedelic medicines.
Otsuka Pharmaceutical’s McQuade...
01/05/2022
Behavioral Healthcare Executive
News
12/11/2021
Tom Valentino, Digital Managing Editor
In a wide-ranging industry forecast, Dreamscape Marketing President and CEO Dan Gemp shared best practices for behavioral healthcare providers’ websites, social media, and other marketing channels.
In a wide-ranging industry forecast, Dreamscape Marketing President and CEO Dan Gemp shared best practices for behavioral healthcare providers’ websites, social media, and other marketing channels.
In a wide-ranging industry...
12/11/2021
Behavioral Healthcare Executive
News
12/09/2021
Tom Valentino, Digital Managing Editor
Cybin has received approval for a Phase 2 trial to evaluate psychedelic-assisted psychotherapy with psilocybin for frontline clinicians experiencing COVID-related distress, Novamind has opened an addiction treatment clinic in Utah, and...
Cybin has received approval for a Phase 2 trial to evaluate psychedelic-assisted psychotherapy with psilocybin for frontline clinicians experiencing COVID-related distress, Novamind has opened an addiction treatment clinic in Utah, and...
Cybin has received approval for...
12/09/2021
Behavioral Healthcare Executive
News
11/25/2021
Tom Valentino, Digital Managing Editor
Cybin has awarded a grant to fund the launch of a psychedelic medicine clinical site at Lenox Hill Hospital in New York, while Delic announced the launch of a family support program at its Ketamine Wellness Centers.
Cybin has awarded a grant to fund the launch of a psychedelic medicine clinical site at Lenox Hill Hospital in New York, while Delic announced the launch of a family support program at its Ketamine Wellness Centers.
Cybin has awarded a grant to...
11/25/2021
Behavioral Healthcare Executive
BHE Psychedelics Podcast
BHE Podcast
11/24/2021
Numinus Wellness CEO and founder Payton Nyquvest discusses the emergence of psychedelics, how psychedelic-assisted psychotherapy integrates with existing treatment modalities, as well as investors' interest and payers' views on psychedelics.
Numinus Wellness CEO and founder Payton Nyquvest discusses the emergence of psychedelics, how psychedelic-assisted psychotherapy integrates with existing treatment modalities, as well as investors' interest and payers' views on psychedelics.
Numinus Wellness CEO and founder...
11/24/2021
Behavioral Healthcare Executive

Advertisement

Advertisement

Advertisement